Navigation Links
ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
Date:2/13/2008

- Data on ARIUS' novel CD9 therapeutic antibody to be presented at AACR

Special Conference on Cancer Stem Cells -

TORONTO, Feb. 13 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that new information on the preclinical activity of its anti-CD9 cancer stem cell antibody will be presented at the AACR Special Conference on Cancer Stem Cells entitled "The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis," held on February 12th-15th in Los Angeles. The Company will disclose data demonstrating that its CD9 antibody not only targets leukemia cancer stem cells, but also leads to a dramatic reduction in their capacity to self-renew or give rise to further leukemia. These findings were discovered in collaboration with John E. Dick, PhD, the Canada Research Chair in Stem Cell Biology with the University Health Network in Toronto, Canada.

The poster presentation (Wednesday, February 13th 2008, from 4:30-6:30 pm) will outline the activity of ARIUS' anti-CD9 antibody, AR40A746.2.3, against acute myeloid leukemia (AML). The long-term survival expectation for patients with AML is poor due to disease relapse and resistance to chemotherapy. CD9 appears to be an important driver for leukemia and potentially other cancer stem cells, which often survive treatment, continue to multiply and go on to seed new tumors. Studies of patients with different types of cancer have demonstrated that the presence of CD9 can be linked to lower survival rates. AR40A746.2.3 has previously been found to control tumor growth and improve survival in pre-clinical breast and pancreatic cancer models.

"Since some cancer stem cells have been shown to be highly resistant to traditional cancer therapies and are believed to contribute to treatment resistance, the selectivity of ARIUS' anti-CD9 antibody for leukemic cancer stem
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS announces fourth quarter and year-end fiscal 2007 financial results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...YandBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/-...heassetsofHylandSeeds,adivisionofThompsonsLimitedo...herexpandDowAgroSciences,currentseedsbusinessasthe...in 2010 andDowAgroSciencesHerbicideTolerantTrait...ctedinthenearfuture. ,, "Thisacquisitionbringst...
(Date:11/24/2009)...VIK,Iceland,November24/PRNewswire-FirstCall/--deCO...provalofallofits,"firstday"motionsbytheU.S.Bankrup...urt").deCODElastweekfiledavoluntarypetitionfor,rel...ththe,BankruptcyCourt. , Theordersissuedbythe...itsbusinessduringtheChapter11proceedings.Inparticu...
(Date:11/24/2009)...E,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.announc...Authority(OPDA)wererecentlyawarded$2millionbyWashi...ERB)inaprivate/publicpartnershiptoconstructthestat...unty,WA. ,, "Thisinvestmentwillsignificantlyspe...njobstoLincolnCounty,"saidBlueMarbleEnergyCEOKelly...
(Date:11/24/2009)...,November24/PRNewswire-FirstCall/--Shireplc(LSE:SH...icalcompany,today,announcedthatithassubmittedaMAAt...hecompany,senzymereplacementtherapyindevelopment,f...marketing,applicationforvelaglucerasealfathathasbe...tesandCanada. , Basedonaglobalsupplyshortageo...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...athDetect reporting system for studying NFAT act... Chao-Feng Zheng ,Stratagene , Stratagenes new...c reporter plasmid, is designed for studying the a...ell (NFAT) transcription factors. These,interest...cible gene expression,during immune responses, a...
... signal transduction pathway of your choice , ...stems, Inc. , The PathDetect in vivo signal tran...for assessing the in vivo activation of signal tra...ng systems include a unique fusion trans-activator...ctivator proteins fused to,the yeast GAL4 DNA bi...
...lasma PCR Primer Set for fast and easy detection o...rrington ,Yale University , D. R. Staggs ,Ge...ene , Mycoplasma contamination of mammalian cell...f transfection reagents. 1 Cells must be free of,...nts of LipoTAXI ,transfection reagent and ...
Other Biology Technology:Cis-Reporting System Monitors Intracellular Calcium Mobilization 2Cis-Reporting System Monitors Intracellular Calcium Mobilization 3Cis-Reporting System Monitors Intracellular Calcium Mobilization 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 5New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 2New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 3New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 4New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 5New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 6Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 2Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 3
(Date:11/24/2009)..., The presence of increased body fat, and there...he blood, hinders the loss and maintenance of body...versity of Navarra conducted by Estbaliz Goyeneche... The project, entitled "A nutrigenetic and nutrige...ght and inflammation," examines how the individual...
(Date:11/23/2009)...train of the deadly superbug MRSAan infection-caus...oses a far greater health threat than previously k...ng to a study in the December issue of Emerging I... picked up in fitness centers, schools, and other ... of MRSA within hospitals, the report found. , T...
(Date:11/23/2009)...ay matters to forest trees dealing with drought, a...m led by Professor Malcolm Campbell, University of... and colleagues in the department of cell and syst...lizing on their previous work to decode the genome...w poplar trees use their 45,000 genes to respond t...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Weight Loss Surgery Simplified 47681 1Weight Loss Surgery Simplified 47681 2Voices Against Brain Cancer Hosts Event to Benefit Brain Cancer Research 47679 1Voices Against Brain Cancer Hosts Event to Benefit Brain Cancer Research 47679 2Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 1Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 2
... Norfolk, VA September 23, 2008 Researchers at ...new international study to explore the safety and ...s with advanced emphysema or Chronic Obstructive P...ay Stents for Emphysema) Trial focuses on airway b...y to create new pathways to release trapped air fr...
...HILTON HEAD, SCAnabolic steroids are synthetic hor...rone. The use of steroids has been suspected in pr...g muscle strength, rather than endurance, is param...earchers has examined the impact of anabolic stero...ad ceased to take the drugs. The researchers found...
...HILTON HEAD, SCThe coordination of two systems are...race. The first are the lower limbs, which allow t... The second is a complicated respiratory system, w...ry stride they make while racing. For more than a ...nlock the secrets of equines. Their findings may p...
Other Biology News:Sentara begins international trial -- open at only 24 US locations 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 3Galloping and breathing at high speed 2Galloping and breathing at high speed 3
Goat Anti-Sarcosine Oxidase Polyclonal Antibody, HRP Conjugated from Abcam
Mouse Anti-Rat ICAM Monoclonal Antibody, PE Conjugated from Antigenix America Inc.
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Mouse Anti-5-Methylcytosine Monoclonal Antibody, Unconjugated, Clone 33D3 from Eurogentec
Biology Products: